Sorafenib in Combination With Locoregional Therapy for Hepatocellular Carcinoma in Patients on the Liver Transplant Waiting List: One Center's Experience

被引：0
|
作者：
Truesdale, Aimee E.
Birkhan, Oscar A.
Shah, Neeral L.
Argo, Curtis K.
Al-Osaimi, Abdullah M.
Caldwell, Stephen H.
Schmitt, Timothy M.
Northup, Patrick G.
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1292
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [1] Role of hepatocellular carcinoma therapy for patients in the waiting list for liver transplant
    Pascual, S.
    Irurzun, J.
    Miralles, C.
    Bernabe, J. M.
    Rodriguez, M.
    Bellot, P.
    Melgar, P.
    Alcazar, C.
    Lluis, F.
    Palazon, J. M.
    Rodriguz-Laiz, G.
    TRANSPLANTATION, 2021, 105 (08) : 130 - 130
  • [2] Risk Factors for Dropout From the Liver Transplant Waiting List of Hepatocellular Carcinoma Patients Under Locoregional Treatment
    Lee, H. A.
    Cho, E. Y.
    Kim, T. H.
    Lee, Y.
    Suh, S. J.
    Jung, Y. K.
    Kim, J. H.
    An, H.
    Seo, Y. S.
    Kim, D. -S.
    Yim, H. J.
    Yeon, J. E.
    Byun, K. S.
    Um, S. H.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3521 - 3526
  • [3] Downstaging of hepatocellular carcinoma prior to liver transplant: Is there a role for adjuvant sorafenib in locoregional therapy?
    Vagefi P.A.
    Hirose R.
    Journal of Gastrointestinal Cancer, 2010, 41 (4) : 217 - 220
  • [4] THE USE OF SORAFENIB IN HEPATOCELLULAR CARCINOMA PATIENTS ON THE LIVER TRANSPLANT WAITING LIST IS ASSOCIATED WITH A HIGHER RATE OF POST-TRANSPLANT COMPLICATIONS
    Truesdale, Aimee E.
    Caldwell, Stephen H.
    Shah, Neeral L.
    Argo, Curtis K.
    Al-Osaimi, Abdullah M.
    Schmitt, Timothy M.
    Northup, Patrick G.
    HEPATOLOGY, 2010, 52 (04) : 1169A - 1170A
  • [5] List and Liver Transplant Survival According to Waiting Time in Patients With Hepatocellular Carcinoma
    Salvalaggio, P. R.
    Felga, G.
    Axelrod, D. A.
    Della Guardia, B.
    Almeida, M. D.
    Rezende, M. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (03) : 668 - 677
  • [6] Treating Hepatocellular Carcinoma With Sorafenib in Liver Transplant Patients: An Initial Experience
    Saidi, R. F.
    Shah, S. A.
    Rawson, A. P.
    Grossman, St
    Piperdi, B.
    Bozorgzadeh, A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4582 - 4584
  • [7] Liver transplantation in patients with hepatocellular carcinoma: One center's experience
    Karakayali, H.
    Sevrnis, S.
    Moray, G.
    Yilmaz, U.
    Ozcay, F.
    Savas, N. A.
    Arslan, G.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (01) : 213 - 218
  • [8] Locoregional Therapy and Recurrence of Hepatocellular Carcinoma After Liver Transplant
    Kirnap, Mahir
    Boyvat, Fatih
    Akdur, Aydincan
    Karakayali, Feza
    Arslan, Gulnaz
    Moray, Gokhan
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 : 166 - 169
  • [9] ASSIGNING MELD SCORE FOR HEPATOCELLULAR CARCINOMA FOR PATIENTS ON WAITING LIST IN A SINGAPORE LIVER TRANSPLANT CENTRE
    Chang, Stephen K. Y.
    Bhasin, Rakesh
    Da Costa, Maureen
    Shridhar, Iyer
    Lee, Victor
    Madhavan, Krishnakumar
    LIVER TRANSPLANTATION, 2008, 14 (07) : S125 - S125
  • [10] TRANSARTERIAL CHEMOEMBOLIZATION UTILITY AS A BRIDGE TO LIVER TRANSPLANT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA DURING THE WAITING LIST
    Perez-Saborido, Baltasar
    Barra-Valencia, Vanessa
    Donat-Garrido, Maria
    Gimeno-Calvo, Alberto
    Jimenez de los Galanes-Marchan, Santos
    Fundora-Suarez, Yillian
    Lopez-Jara, Vanesa
    Carlos Meneu-Diaz, Juan
    Adradelo de Usera, Manuel
    Moreno-Gonzalez, Enrique
    TRANSPLANT INTERNATIONAL, 2009, 22 : 212 - 213
12345